![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Impact of all-oral direct-acting antivirals on clinical and economic outcomes in chronic hepatitis C virus-infected patients in the U.S.
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Haesuk Park, Assistant Professor,
University of Florida College of Pharmacy
![1113181](../images%20/111318/111318-12/1113181.gif)
![1113182](../images%20/111318/111318-12/1113182.gif)
![1113183](../images%20/111318/111318-12/1113183.gif)
![1113184](../images%20/111318/111318-12/1113184.gif)
![1113185](../images%20/111318/111318-12/1113185.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|